| Literature DB >> 28361682 |
Junpeng Zhang1, Thuc D Le2, Lin Liu2, Jiuyong Li3.
Abstract
BACKGROUND: MicroRNA (miRNA) sponges with multiple tandem miRNA binding sequences can sequester miRNAs from their endogenous target mRNAs. Therefore, miRNA sponge acting as a decoy is extremely important for long-term loss-of-function studies both in vivo and in silico. Recently, a growing number of in silico methods have been used as an effective technique to generate hypotheses for in vivo methods for studying the biological functions and regulatory mechanisms of miRNA sponges. However, most existing in silico methods only focus on studying miRNA sponge interactions or networks in cancer, the module-level properties of miRNA sponges in cancer is still largely unknown.Entities:
Keywords: Biclustering method; Breast cancer; Regulatory score; ceRNA; miRNA sponge; miRNA sponge module
Mesh:
Substances:
Year: 2017 PMID: 28361682 PMCID: PMC5374547 DOI: 10.1186/s12859-017-1467-5
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Fig. 1The pipeline of miRSM. We construct miRNA-mRNA correlation matrix using Pearson method, and miRNA-mRNA context++ score matrix using putative miRNA-target binding information. Next, miRNA-mRNA regulatory score matrix is inferred by combining miRNA-mRNA correlation and context++ score matrix. A biclustering method is then used to generate miRNA-mRNA biclusters. We identify miRNA sponge interactions in each miRNA-mRNA bicluster, and remove the candidate miRNA sponges which are not involved in any miRNA sponge interactions. The remaining candidate miRNA sponges and miRNAs in each bicluster are considered as a miRNA sponge module
miRNA sponge modules in BRCA
| miRSM | #miRNAs | #miRNA sponges | #miRNA sponge interactions |
|---|---|---|---|
| Module 1 | 110 | 546 | 69468 |
| Module 2 | 130 | 1213 | 470817 |
| Module 3 | 92 | 1142 | 422427 |
| Module 4 | 105 | 354 | 37952 |
Fig. 2Overlaps and differences of miRNA sponge interactions in the four miRNA sponge modules
Fig. 3The percentage of BRCA miRNAs, BRCA miRNA sponges, and cancer hallmark miRNA sponges in the four miRNA sponge modules
Top 5 enriched GO terms and KEGG pathways for the miRNA sponges in each module and module-specific interactions
| miRSM | Items | #miRNA sponges | Adjusted |
|---|---|---|---|
| Module 1 | GO:0000278-Mitotic cell cycle | 45 | 7.36E-28 |
| GO:0051301-Cell division | 43 | 4.10E-27 | |
| GO:0007049-Cell cycle | 41 | 4.61E-18 | |
| GO:0007067-Mitosis | 28 | 2.50E-17 | |
| GO:0000236-Mitotic prometaphas | 20 | 3.59E-16 | |
| KEGG:04110-Cell cycle | 17 | 7.73E-10 | |
| KEGG:04914-Progesterone-mediated oocyte maturation | 9 | 0.000432 | |
| KEGG:05110-Vibrio cholerae infection | 7 | 0.000676 | |
| KEGG:03060-Protein export | 5 | 0.000728 | |
| KEGG:04114-Oocyte meiosis | 9 | 0.001271 | |
| Module 2 | GO:0007165-Signal transduction | 124 | 2.37E-26 |
| GO:0007275-Multicellular organismal development | 106 | 1.41E-24 | |
| GO:0045944-Positive regulation of transcription from RNA polymerase II promoter | 73 | 2.16E-19 | |
| GO:0000122-Negative regulation of transcription from RNA polymerase II promoter | 55 | 3.39E-15 | |
| GO:0007155-Cell adhesion | 62 | 9.26E-14 | |
| KEGG:04060-Cytokine-cytokine receptor interaction | 35 | 5.45E-10 | |
| KEGG:04080-Neuroactive ligand-receptor interaction | 33 | 1.40E-08 | |
| KEGG:05200-Pathways in cancer | 36 | 2.53E-08 | |
| KEGG:04510-Focal adhesion | 26 | 1.40E-07 | |
| KEGG:04144-Endocytosis | 25 | 3.30E-07 | |
| Module 3 | GO:0007165-Signal transduction | 113 | 1.01E-22 |
| GO:0045944-Positive regulation of transcription from RNA polymerase II promoter | 73 | 6.85E-21 | |
| GO:0007275-Multicellular organismal development | 94 | 5.77E-20 | |
| GO:0000122-Negative regulation of transcription from RNA polymerase II promoter | 52 | 1.98E-14 | |
| GO:0007155-Cell adhesion | 58 | 9.76E-13 | |
| KEGG:04060-Cytokine-cytokine receptor interaction | 31 | 4.46E-08 | |
| KEGG:04080-Neuroactive ligand-receptor interaction | 31 | 5.24E-08 | |
| KEGG:05200-Pathways in cancer | 34 | 6.92E-08 | |
| KEGG:04920-Adipocytokine signaling pathway | 15 | 9.78E-08 | |
| KEGG:04010-MAPK signaling pathway | 29 | 2.07E-07 | |
| Module 4 | GO:0000278-Mitotic cell cycle | 42 | 2.03E-32 |
| GO:0051301-Cell division | 40 | 2.79E-31 | |
| GO:0000236-Mitotic prometaphase | 20 | 6.71E-20 | |
| GO:0007067-Mitosis | 26 | 7.54E-20 | |
| GO:0006260-DNA replication | 24 | 8.54E-20 | |
| KEGG:04110-Cell cycle | 14 | 2.48E-09 | |
| KEGG:03060-Protein export | 5 | 0.00015 | |
| KEGG:05110-Vibrio cholerae infection | 6 | 0.000517 | |
| KEGG:04914-Progesterone-mediated oocyte maturation | 6 | 0.003029 | |
| KEGG:04141-Protein processing in endoplasmic reticulum | 8 | 0.003089 | |
| Module-specific | GO:0007275-Multicellular organismal development | 146 | 6.67E-30 |
| GO:0007165-Signal transduction | 165 | 2.46E-29 | |
| GO:0045944-Positive regulation of transcription from RNA polymerase II promoter | 95 | 5.49E-21 | |
| GO:0000122-Negative regulation of transcription from RNA polymerase II promoter | 72 | 7.02E-17 | |
| GO:0007264-Small GTPase mediated signal transduction | 58 | 6.02E-15 | |
| KEGG:05200-Pathways in cancer | 56 | 2.26E-13 | |
| KEGG:04510-Focal adhesion | 39 | 2.92E-11 | |
| KEGG:04144-Endocytosis | 34 | 1.77E-08 | |
| KEGG:04060-Cytokine-cytokine receptor interaction | 39 | 7.93E-08 | |
| KEGG:04810-Regulation of actin cytoskeleton | 34 | 9.26E-08 |
The p-values are adjusted by Benjamini-Hochberg (BH) method
Comparison with other existing three methods in the number of breast cancer-related miRNA sponge interactions and experimentally validated miRNA sponge interactions
| Methods | #Interactions | #Breast cancer-related interactions (percentage) | Validated miRNA sponge interactions | #Validated interactions |
|---|---|---|---|---|
| miRSM_default | 577544 | 21669 (3.75%) | SERINC1:PTEN, LRCH1:PTEN, KLF6:PTEN, ZEB2:PTEN, MBNL1:PTEN | 5 |
| miRSM_v1 | 169617 | 6104 (3.60%) | SERINC1:PTEN, LRCH1:PTEN, KLF6:PTEN, ZEB2:PTEN, MBNL1:PTEN | 5 |
| miRSM_v2 | 1228533 | 46186 (3.76%) | SERINC1:PTEN, LRCH1:PTEN, KLF6:PTEN, ZEB2:PTEN, MBNL1:PTEN | 5 |
| PC | 933516 | 28354 (3.04%) | HIAT1:PTEN, SERINC1:PTEN, KLF6:PTEN, TNKS2: PTEN, PDGFRA:RB1, LRCH1:PTEN, AFF1:PTEN | 7 |
| SPPC | 177371 | 6434 (3.63%) | LRCH1:PTEN, KLF6:PTEN | 2 |
| Hermes | 43144 | 1018 (2.36%) | JARID2:PTEN, RUNX1:PTEN, AFF1:PTEN | 3 |
“:” denotes “competing with”. Three miRSM networks including miRSM_default with a = b = 0.5 and s = -0.3, miRSM_v1 with a = 0.45, b = 0.55 and s = -0.3, and miRSM_v2 with a = 0.55, b = 0.45 and s = -0.3 are used to compare
Fig. 4Overlaps and differences between PTEN-related miRNA sponge interactions identified by miRSM, PC, SPPC, and Hermes
The number of identified miRNA sponge interactions and experimentally validated miRNA sponge interactions under different parameter settings
| Parameter settings of miRSM | #Interactions | Validated miRNA sponge interactions | #Validated interactions |
|---|---|---|---|
|
| 577544 | SERINC1:PTEN, LRCH1:PTEN, KLF6:PTEN, ZEB2:PTEN, MBNL1:PTEN | 5 |
|
| 2033124 | AFF1:PTEN, ZEB2:PTEN, SERINC1:PTEN, MBNL1:PTEN, LRCH1:PTEN, KLF6:PTEN, FN1: VCAN | 7 |
|
| 61161 | / | 0 |
|
| 1041 | / | 0 |
|
| 84 | / | 0 |
|
| 17972 | LRCH1:PTEN, KLF6:PTEN | 2 |
|
| 169617 | SERINC1:PTEN, LRCH1:PTEN, KLF6:PTEN, ZEB2:PTEN, MBNL1:PTEN | 5 |
|
| 1228533 | SERINC1:PTEN, LRCH1:PTEN, KLF6:PTEN, ZEB2:PTEN, MBNL1:PTEN | 5 |
|
| 2029912 | AFF1:PTEN, ZEB2:PTEN, SERINC1:PTEN, MBNL1:PTEN, LRCH1:PTEN, KLF6:PTEN, FN1:VCAN | 7 |